HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,772,000 | +3.9% | 654,362 | +2.4% | 2.02% | +55.2% |
| Q4 2019 | $11,327,000 | -3.7% | 638,870 | -15.8% | 1.30% | +28.8% |
| Q3 2019 | $11,765,000 | -15.5% | 758,553 | -6.3% | 1.01% | -2.7% |
| Q2 2019 | $13,915,000 | +9.6% | 809,955 | +2.7% | 1.04% | +13.7% |
| Q1 2019 | $12,698,000 | +17.2% | 788,701 | +6.5% | 0.92% | +1.8% |
| Q4 2018 | $10,838,000 | -0.9% | 740,816 | +23.1% | 0.90% | +52.4% |
| Q3 2018 | $10,933,000 | – | 601,693 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |